Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

117.18USD
19 Dec 2014
Price Change (% chg)

$0.70 (+0.60%)
Prev Close
$116.48
Open
$117.74
Day's High
$118.73
Day's Low
$115.46
Volume
11,294,289
Avg. Vol
5,223,265
52-wk High
$119.84
52-wk Low
$66.85

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
14 Dec 2014

Daniel Thomas O

Officer Sell 30,000 $115.06
14 Dec 2014

Daniel Thomas O

Officer Buy 30,000 $29.75
7 Dec 2014

Kaplan Gilla

Director Buy 15,000 $7.09
7 Dec 2014

Kaplan Gilla

Director Sell 15,000 $118.20
29 Nov 2014

Smith Scott Andrew

Officer Buy 6,670 $0.00
29 Nov 2014

Smith Scott Andrew

Officer Sell 3,458 $113.69
23 Nov 2014

Daniel Thomas O

Officer Sell 33,818 $110.27
23 Nov 2014

Daniel Thomas O

Officer Buy 33,818 $0.00
11 Nov 2014

KARSEN PERRY A

Officer Buy 11,250 $25.77
11 Nov 2014

KARSEN PERRY A

Officer Sell 39,420 $107.23
11 Nov 2014

KARSEN PERRY A

Officer Buy 12,500 $36.96
11 Nov 2014

KARSEN PERRY A

Officer Buy 8,324 $36.47
2 Nov 2014

Hugin Robert J

Chief Executive Officer Buy 144,400 $7.13
2 Nov 2014

Hugin Robert J

Chief Executive Officer Buy 40,000 $13.37
2 Nov 2014

Hugin Robert J

Chief Executive Officer Buy 40,000 $10.30
2 Nov 2014

Hugin Robert J

Chief Executive Officer Buy 40,000 $8.56
2 Nov 2014

Hugin Robert J

Chief Executive Officer Buy 240,000 $17.84
2 Nov 2014

Hugin Robert J

Chief Executive Officer Sell 433,858 $107.41
2 Nov 2014

Hugin Robert J

Chief Executive Officer Sell 158,000 $106.68
2 Nov 2014

Hugin Robert J

Chief Executive Officer Buy 240,000 $17.02
26 Oct 2014

Mario Ernest B

Director Sell 100,000 $102.85
23 Oct 2014

Casey Michael D

Director Buy 15,000 $7.09
23 Oct 2014

Casey Michael D

Director Sell 15,000 $102.94
7 Sep 2014

Kaplan Gilla

Director Sell 30,000 $93.73
7 Sep 2014

Kaplan Gilla

Director Buy 30,000 $7.25

Institutional Holders

% Shares Owned: 84.05%
# of Holders: 1,406
Total Shares Held: 671,343,962
3 Mo. Net Change: 3,695,694
# New Positions: 115
# Closed Positions: 70
# Increased Positions: 578
# Reduced Positions: 585
# Net Buyers: -7

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Peter Kellogg

58 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Tuomo Patsi

President - Europe, Middle East and Africa (EMEA)

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks